Importantly, this neuroprotective peptide also counteracts TrkB‐FL downregulation in mouse ischemia, where it efficiently decreases infarct size and improves neurological outcome, unraveling a highly relevant strategy for stroke therapy. This evidence concerns the gene NTRK2 and ischemia.